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Abstract
The mechanism of cell-cell contact dependent regulation of pericellular proteolysis in angiogenesis was examined
by studying the expression of MMPs using isolated HUVECs in culture. Zymography, Immunoblot and RT-PCR
analysis showed that the production and secretion of matrixmetalloproteinase-2 and matrixmetalloproteinase-9 by
HUVECs in culture were high when they remain as individual cells and significantly decreased during later stages
of culture when cells developed cell-cell contact and tubular network-like structure. As MMPs decreased there was
significant upregulation of VE-cadherin in cells undergoing angiogenic transition. Investigations to understand the
signaling pathways downstream of VE-cadherin showed a relatively high level of b-catenin in the nucleus of
endothelial cells in culture during initial stages and decrease in its levels in the nucleus, associated with an increase
in the cytosol during later stages of culture. The distribution of b-catenin was found to be regulated by Tyr/Ser
phosphorylation status of this protein. Cell-cell contact dependent downregulation of MMPs during angiogenesis
was also observed in experiments using proangiogenic substances which caused a rapid rate of downregulation of
MMP-2 and MMP-9 and absence of downregulation of MMPs when treated with anti-angiogenic agents.
Introduction
The ability of ECs (endothelial cells) and their support-
ing cellular elements to modify their immediate sur-
rounding extracellular matrix (ECM) responding to
multiple signals received from the environment is criti-
cally important during angiogenesis [1,2]. Both cell-cell
and cell-matrix interactions are crucial in the transition
of endothelial cell phenotype associated with angiogen-
esis [3,4]. These interactions are governed by changes in
both cell surface receptor for matrix proteins and the
nature of the ECM. Matrixmetalloproteinases (MMPs),
by virtue of their ability to degrade components of the
ECM can influence these processes by altering the com-
position and structural organization of the ECM,
thereby altering matrix-derived signals [1]. Tight regula-
tion of the activity of MMP is required during angiogen-
esis as excessive proteolysis can cause unwanted damage
to the cells and might dissolve the matrix, cell adhesion
molecules and receptors needed for anchoring the
migrating cells and for the maturation of the neo-vessel
[1,5].
A temporal relation between the production of MMPs
and the onset of angiogenesis has been reported [6].
Down regulation of MMP-2 and MMP-9 under condi-
tions where human umbilical vein endothelial cells
(HUVECs) undergo morphological changes to form tub-
ular network-like structure and higher levels of these
enzymes under conditions where cell-cell contact was
less and formation of such structures did not occur,
suggest that down regulation of MMP production by
endothelial cells is crucial to angiogenic process [6].
Further, MMPs have been reported to alter with change
in endothelial cell shape where maximum activity was
reported when the cells were spherical in shape [7].
Apart from MMPs, cell adhesion molecules are also
equally important regulators of angiogenesis. They form
intercellular junctions between endothelial cells, which
give the endothelium the ability to control the passage of
solutes and circulating cells [8] and endothelial surface
polarity [9]. They regulate the initiation and maturation of
newly formed vessels during angiogenesis. The initiation
of angiogenesis occurs when the continuity of the
endothelial layer is interrupted due to the loosening of the
cell-cell contacts enabling the endothelial cells to prolifer-
ate and migrate to the free area [10,11]. During the later
stages of angiogenesis (maturation phase) it is essential
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tacts in order to maintain the morphological integrity and
quiescence of the newly formed vessel [12,13]. It thus
appears that the molecular mechanisms that govern for-
mation and stabilization of cell-cell contact and pericellu-
lar proteolysis are suitably coordinated and regulated.
Recent efforts to understand the functional link between
cell-cell adhesion and pericellular proteolysis provided
data in support of a role for E-cadherin (epithelial-cad-
herin) in the regulation of expression of MMPs in epithe-
lial cells [14]. Lower expression of MMPs in cancer cells
overexpressing E-cadherin and upregulation of MMPs
associated with downregulation of E-cadherin expression
has been observed [15-17]. Further, blocking cell-cell junc-
tion formation in pre-malignant keratinocytes by function
blocking antibodies against E-cadherin caused up regula-
tion of MMP-9 [18]. But mechanisms regulating the
expression of MMPs in endothelial cells during angiogen-
esis are still unclear. MMPs have been reported to
be regulated at transcriptional, translational and post-
translational levels [19]. Nuclear factor kappa B (NFB)
and activator protein-1 (AP-1) signaling pathways have
been reported to be the major signaling pathways in the
regulation of MMP expression [19]. But it is unlikely that
these pathways are involved in the downregulation of
MMPs during angiogenesis as significant activation of
these signaling pathways as evidenced by the upregulation
of a number of genes responsive to these transcription fac-
tors occur in ECs during angiogenesis [20,21]. The down-
regulation of MMPs at later stages of angiogenesis when
cell-cell contacts are established and tubular network-like
structures are formed tempted us to postulate cell-cell
contact dependent mechanisms in the regulation of
MMPs. Recent reports indicate that the components of
the intercellular adheren junctions also function in intra-
cellular signaling during angiogenesis [22]. VE-cadherin
(vascular endothelial-cadherin) has been reported to be
the major endothelial specific cell adhesion molecule that
plays important role in vascular morphogenesis and
growth control [23]. The molecular mechanisms involved
in cell-cell contact dependent regulation of MMPs in
endothelial cells undergoing angiogenic process was exam-
ined using HUVECs in culture and the results show
reciprocal changes in the expression of MMP-2 and
MMP-9 and VE-cadherin as the cells undergo angiogenic
transition.
Materials and methods
Materials
MCDB131-medium, gentamycin, antibiotic-antimycotic
solution, gelatin, ortho-dianisidine, DEPC, curcumin, urso-
lic acid, gelatin, FCS, diaminob e n z i d i n e ,T r i s ,g l y c i n e ,
bovine serum albumin, protein A-sepharose beads, antibo-
dies to MMP-2 (M4065), MMP-9 (M5427), VE-cadherin
(C1821), b-catenin (C2206), CD 31 (C7714), CD
14 (C7673), CD 71 (C2063), phospho tyrosine (P5872),
phospho serine (P5747), HRP (A6154, A0168) and FITC
(F6397) conjugated secondary antibody were purchased
f r o mM / sS i g m aA l d r i c hC o( S t .L o u i s ,M I ) .N Cm e m -
brane was from BioRad laboratories, Hercules, CA. ELISA
and tissue culture plates were from NUNC A/S (Roskilde,
Denmark). Perfect RNA mini isolation kits and C-Master
RT Plus PCR kits were purchased from Eppendorf (Eppen-
dorf AG, Hamburg, Germany).
Methods
Isolation and culture of HUVECs
Endothelial cells were isolated by collagenase perfusion
of umbilical vein as described before [24]. The yield and
viability of isolated HUVECs were determined by trypan
blue staining. 1.5 × 10
6 cells per well in MCDB 131
medium were seeded in NUNC multi-well plates and
allowed to attach for 5 hrs, unattached cells were
removed, fresh serum-free medium was added and
maintained in culture overnight before starting the
experiment. The purity of the cultures was assessed by
checking for possible contamination with other cell
population like monocyte/macrophage by monitoring
expression of CD 14 and CD 71 by immunocytochem-
ical technique. The cultures were negative for both the
CD markers. Further, FACS analysis of the cultures
showed that about 99.8% cells were CD 31 positive. All
the experiments were performed according to the guide-
lines of the Institutional Ethical Committee.
Enzyme Linked Immunosorbent Assay (ELISA)
Indirect ELISA was performed using specific antibody
[25]. Cell culture medium precoated onto ELISA plates
served as the antigen. o-dianisidine was used as sub-
strate and the absorbance of the coloured horse radish
peroxidase (HRP) product was measured spectrophoto-
metrically at 405 nm by an automated microplate reader
(Thermo Multiskan Sprectrum).
Reverse Transcriptase-Polymerase Chain Reaction (RT-
PCR) analysis
Total RNA was isolated from HUVECs using Perfect RNA
Mini isolation kits procured from Eppendorf according
to manufacturer’s instruction. The primer pairs for
human MMP-2, MMP-9, VE-cadherin, b-catenin and
GAPDH were as follows; MMP-2 (195 bp) Forward
5’ATGGGGAATCGGTTGAAGG3’ Reverse 5’AATTG-
CATTTCCTGACAGAAGG3’; MMP-9 (147 bp) Forward
5’GACTTGGCAGTGGAGACTGCGGGCA3’ Reverse
5’GACCCCACCCC TCCTTGACAGGCAA3’;V E - c a d -
herin (149 bp) Forward 5’GCACCAGTTTGGCCAATATA
3’ Reverse 5’GGGTTTTTGCATAATAAGCAGG3’; b-
catenin (291 bp); Forward 5’TTTTTAAA GGCAAG
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TAGCCCA3’ and GAPDH (680 bp) Forward 5’CGGAGT-
CAACGGATTTGGTCGTAT3’ Reverse 5’GCAGGTCAG
GTCC ACCACTAGC3’. The primer sequences were taken
from NCBI nucleotide database and custom synthesized by
Sigma Aldrich Chemicals Bangalore, India. RT-PCR was
performed in an Eppendorf thermocycler, using the
C-Master RT Plus PCR kit (Eppendorf AG, Hamburg,
Germany). 20 μl( 2μg )o ft h ei s o l a t e dR N Aw a su s e da s
template for reverse transcription and amplification as
described before [26].
Immunoblot Analysis
Medium was removed, cells were washed with phos-
phate buffered saline (PBS), scraped from the culture
plates, centrifuged and the cell pellets were lysed in
Laemmli sample buffer. Protein equivalent amount of
the lysates were subjected to sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) on 10%
polyacrylamide gels. Proteins were transferred to the
nitrocellulose (NC) membrane using a semidry blotting
apparatus, probed with specific antibody and developed
using HRP-conjugated secondary antibody [27]. Appro-
priate negative controls were taken without primary
antibody. The band intensity was determined by Quan-
tity One 4.5.0 Image acquisition and Analysis software
(BioRad).
Zymography
The activity of MMPs secreted by HUVECs into the
medium maintained in culture was determined by gela-
tin zymography [28]. Zymogram gels consisted of 7.5%
polyacrylamide (native) gel polymerized together with
gelatin (1 mg/ml). After electrophoresis, the gels were
washed twice with 2.5% Triton × 100 and incubated
with substrate buffer (50 mM Tris, 5 mM CaCl2,p H
7.5) at 37°C for 24 hrs. The gels were stained with Coo-
massie brilliant blue R 250 and destained with water.
Gelatinolytic activities appearing as clear zone were
quantitated using Quantity One - 4.5.0 - Software
(BioRad).
Distribution of b-Catenin
Cell pellets were resuspended in 500 μl PBS ice-cold
nuclear buffer (150 mM NaCl, 150 mM sucrose, 20 mM
HEPES, pH 7.4, 5 mM KCl, 2 mM dithiothreitol, 1 mM
MgCl2,0 . 5m MC a C l 2,0 . 1m MP M S F ,a n dp r o t e a s e
inhibitors) [29]. The suspension was gently mixed with a
pipette on ice for 3 min and then centrifuged at 500 × g
for 10 min to pellet the nuclei. The cytosolic superna-
tant was centrifuged for 60 min at 13000 × g at 4°C.
Protein equivalent amount of cytosolic and nuclear frac-
tions were resolved on SDS polyacrylamide gels and
immunoblotted to analyse the levels of b-catenin in
nucleus and cytosolic fraction. For immunoprecipitation,
equivalent amount of cellular proteins were brought to
a volume of 1.0 ml in buffer containing 50 mM
Tris-HCl, pH 7.5, 0.4 M NaCl, 5 mM EDTA and 0.5%
NP-40. The clear supernatant was incubated with the
anti-b-Catenin antibody for 2 hrs on ice followed by
Protein A/G-Sepharose for immunoprecipitation. Beads
were washed 3 times with the same buffer and extracted
in Laemmli sample buffer; subjected to SDS-PAGE, elec-
troblotted and probed with monoclonal antibodies
against phosphotyrosine and phosphoserine.
Statistical Analysis
The statistical significance of difference was analysed by
Duncan’s one way Analysis of Variance (ANOVA) using
SPSS10 Software.
Results
Production of matrix metalloproteinases by HUVECs
As reported earlier, with the progression of culture
endothelial cell-cell contact, grouping and tubular net-
work-like structures developed [6,20]. In agreement with
this data [6], HUVECs in culture in MCDB 131 medium
that promoted angiogenic phenotype produced MMP-2
and MMP-9. Zymographic analysis showed a steady
decrease in the activity of MMP-2 and MMP-9 with the
progression of culture (Figure 1A&1B). Analysis of pro-
tein level expression by ELISA (Figure 1C) and western
blot (data not given) also showed a decrease in both
MMP-2 and MMP-9 which on the 5
th day was less than
40% of that on the 1
st day. Although there was no sig-
nificant difference in the activity of MMP-2 and MMP-9
on the 2
nd day when compared to that on the 1
st day,
the levels of the proteins were about 10-15% more on
the 2
nd day. RT-PCR analysis was done to confirm
whether the decrease in the activity of MMP-2 (Figure
2A) and MMP-9 (Figure 2B) was associated with the
downregulation of gene expression. The levels of
mRNAs of both MMP-2 and MMP-9 significantly
decreased with the progression of culture which on the
fifth day of culture was less than 30% of that on the first
day in cells (Figure 2C).
Inorder to further examine whether the downregula-
tion of MMPs is related with the formation of cell-cell
contact and angiogenic transition, experiments were
performed with substances which promoted or inhibited
cell-cell contact and angiogenic phenotype in HUVECs
[20,21]. The downregulation of MMPs associated with
development of angiogenic morphology was tested using
ursolic acid, a naturally occurring substance that caused
proangiogenic effect in HUVECs and accelerated group-
ing of cells and cell-cell contact formation in serum free
MCDB 131 medium [20]. Zymographic analysis showed
that ursolic acid caused downregulation of MMP-2 and
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controls (Figure 3Aa); ursolic acid at a concentration of
50 μM caused reduction of MMP-2 and MMP-9 to
about 40% of that of the initial levels on the 2
nd day
(Figure 3B). Protein level expression of MMP-2 and
MMP-9 also was reduced to about 35% of that of the
initial levels on the second day in cells treated with
ursolic acid (Figure 3C).
It was reported that curcumin caused opposing effects
on angiogenesis under different conditions [21]; while in
serum free MCDB131 medium it exerted a proangiogenic
effect by accelerating the vascular endothelial growth fac-
tor (VEGF) mediated signaling, under serum supplemen-
ted conditions it exerted anti-angiogenic effect. The
changes in MMP activity in HUVECs in response to cur-
cumin were studied in presence and absence of serum.
Zymographic analysis showed a steady decrease in the
activity of MMP-2 and MMP-9 with the progression of
culture in cells treated with curcumin in serum free con-
ditions, the rate of decrease being more than untreated
controls (Figure 3A). The activity of MMP-2 and MMP-9
on the second day was less than 25% of that on the first
day in cells treated with curcumin whereas in untreated
control it was not significantly different from that of 1
st
day. Analysis of protein level expression by ELISA and
Figure 1 Production of MMP-2 and MMP-9 by HUVECs:
Equivalent aliquots of the medium normalized to the total cell
protein from the cultures of HUVECs maintained in MCDB 131
medium collected at intervals of 24 hrs were subjected to
zymography (A) and ELISA (C) as described in text. Lanes 1-5 1
st-5
th
day. The activity of MMP-9 and MMP-2 in zymogram was
quantitated using Quantity One 4.5.0 software BioRad geldoc and
expressed in arbitrary units of intensity/mm
2/mg protein (B). Values
given are the average of intensity measurement of 6 experiments ±
SEM. The protein level expression quantitated for MMP-9 and MMP-
2 by ELISA using specific antibody (C). Values given are the average
of duplicate analysis of 5 experiments ± SEM. * Statistically
significant compared to the production on first day p < 0.05.
Figure 2 Expression of MMP-2 and MMP-9 in HUVECs - RT-PCR:
Cells were maintained in MCDB 131 medium for different time
intervals. Medium was removed and the cell layer harvested, total
RNA was isolated and subjected to RT-PCR as described in the text.
Samples were resolved on 1.75% agarose gel MMP-2 (A) and MMP-
9( B). Intensity of bands were quantitated and normalized with the
intensity of band for internal control GAPDH and expressed as
intensity/mm2 (C). * Statistically significant when compared to their
production on first day p < 0.05.
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the total cell protein from the culture of control, ursolic acid (50 μM), curcumin (10 μM) and aspirin (100 μM) treated cells on days 1 to 4 were
subjected to zymography (A) as described in the text.(a) Lanes 1-4, 50 μM ursolic acid treated cells 1
st -4
th day, Lanes 5-8, control 1
st-4
th day.
(b) Lanes 1-4, 10 μM curcumin treated cells 1
st -4
th day, Lanes 5-8, aspirin treated cells 1
st-4
th day. The activity of MMP-9 and MMP-2 in
zymogram was quantitated using Quantity One 4.5.0 software BioRad geldoc and expressed in arbitrary units of intensity/mm
2/mg protein (B).
Values given are the average of intensity measurement of 6 experiments ± SEM. The culture medium collected from control, ursolic acid (50
μM), curcumin (10 μM) and aspirin (100 μM) treated cells at intervals of 24 hrs (normalized to the total cell protein) were quantitated for MMP-9
and MMP-2 protein expression by ELISA using specific antibody (C). Values given are the average of duplicate analysis of 5 experiments ± SEM.
* Statistically significant compared to the production on first day (p < 0.05) # Statistically significant compared to controls (p < 0.05).
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MMP-2 and MMP-9 was more than the untreated con-
trol and was related with the angiogenic transition (Fig-
u r e3 C ) .U n l i k ei ns e r u mf r e em e d i u m ,t r e a t m e n to f
HUVECs with curcumin in serum supplemented condi-
tion [21], did not cause any downregulation of the activ-
ity (Figure 4Aa) or protein level expression (Figure
4Bd&4e) of MMP-2 and MMP-9. These results suggest
that the downregulation of MMPs in HUVECs treated
with curcumin in the absence of serum, was unlikely to
be an effect of curcumin on MMP production, rather it
was related with the angiogenic transition of the cells.
Acetyl salicylic acid (aspirin) is reported to inhibit
capillary network-like structure formation and angiogen-
esis [6]. The relation between cell-cell contact formation
and MMP production was further tested in HUVECs
treated with aspirin which inhibited the formation of
cell-cell contact [6]. No downregulation of activity and
protein levels of MMP-2 and MMP-9 was observed in
cells treated with aspirin (Figure 3Ab).
Production of VE-cadherin in HUVECs
In order to understand whether there is any relation
between the cell-cell contact formation and MMP pro-
duction, the kinetics of production of VE-cadherin, the
intercellular cell adhesion molecule involved in endothe-
lial cell-cell interaction and angiogenesis was analysed
by western blotting. There was significant increase in
the amount of this protein with the progression of cul-
ture which on the fourth day was about 4 fold more
than that on the first day (Figure 5C). The expression of
V E - c a d h e r i ni nH U V E C sm a i n t a i n e di nc u l t u r ew a s
further confirmed by flow cytometry (data not shown).
RT-PCR analysis also showed that the level of mRNA of
VE-cadherin progressively increased with the progres-
sion of culture (Figure 5A). About four fold increase in
the expression of VE-cadherin was observed in cells on
the fifth day when compared to its production on the
first day of culture indicating an inverse relation
between the changes in the expression of VE-cadherin
and MMP-2 and MMP-9 (Figure 5B).
Production and distribution of b-catenin
b-catenin is one of the accessory proteins associated with
the cytoplasmic tail of VE-cadherin aiding the stabilization
of cell-cell adhesion. When unbound to VE-cadherin,
b-catenin from cytoplasm can translocate into the nucleus.
The relative levels of this protein in the cytosol and
nucleus were analysed by western blotting and the results
are shown in Figure 6. During the initial stages (upto 48
hrs) of culture, almost the entire amount of b-catenin was
present in the nucleus, which declined thereafter concomi-
tantly with significant increase in its level in the cytoplasm
during later stages of culture (Figure 6A); on the third day
only about 50% of the total b-catenin was present in the
nucleus, which declined further with the progression of
culture (Figure 6B&6C).
Inorder to further examine the relation between the
production of cell-adhesion molecules and MMPs by
ECs during angiogenesis, changes in cadherin and cate-
nin with the progression of culture were studied in cells
treated with curcumin under serum free conditions. The
results are given in Figure 7A. There was significant
increase in the amount of VE-cadherin with the progres-
sion of culture which on the fourth day was about 4 fold
more than that on the first day. RT-PCR analysis also
showed that the level of mRNA of VE-cadherin in cur-
cumin treated cells progressively increased with the pro-
gression of culture (data not given).
Analysis of the relative levels of b-catenin in the
nucleus and cytoplasm of the cells treated with curcumin
showed relatively higher levels of this protein in the
nucleus during initial stages (upto 48 hrs) which declined
thereafter concomitantly with significant increase in its
levels in the cytosol during the later stages of culture
(Figure 7B). In cells treated with curcumin only about
25% of the total b-catenin was present in the nucleus on
the third day of culture. Immunocytochemical analysis of
b-catenin in HUVECs maintained in culture for 24 hrs
and 120 hrs further confirmed the presence of b-catenin
in nucleus in ECs during initial stages (24 hrs) and their
localization at the cell contact sites during later stages of
culture (120 hrs) when ECs formed extensive cell-cell
contact and capillary network-like structures (Additional
File 1, Figure S1 and Additional File 2, Figure S2).
Changes in the tyrosine and serine phosphorylation of
b-catenin
In order to understand the phosphorylation status of
b-catenin, the trigger that directs the nuclear transloca-
tion of cytosolic b-catenin, it was immunoprecipitated
and probed with specific phospho-antibody and the
results are shown in Figure 8.
The changes in the phosphorylation of tyrosine and ser-
ine in b-catenin in cells treated with curcumin in serum
free and serum supplemented conditions for different peri-
ods were also studied. The extent of tyrosine phosphoryla-
tion of b-catenin on 3
rd day in culture was significantly
less than that on the first day and that of serine phosphor-
ylation was more on third day than the first day in culture
in serum free condition. Since there was difference in the
extent of phosphorylation among different treatments, the
intensity of each was expressed as percentage of the sum
of the intensities of bands corresponding to P-Tyr and
P-Ser. The relative levels of tyrosine phosphorylation to
serine phosphorylation of b-catenin was high during the
initial stages of culture which decreased as the level of
serine phosphorylation increased during later stages of
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of tyrosine phosphorylation to serine phosphorylation of
b-catenin was observed to be 1:1 in cells treated with cur-
cumin in presence of serum which remained unaffected
throughout the culture.
Effect of Lithium on MMP production by HUVECs in
culture
To examine whether the activation of b-catenin is asso-
ciated with the changes in MMPs, the effect of inhibi-
tion of the glycogen synthase kinase-3 (GSK-3), an
Figure 4 Effect of supplementation of curcumin in presence of serum on the production and activities of MMP-2 and MMP-9:
(A) Equivalent aliquots of the medium appropriately diluted (1:10)from the culture of FCS control and curcumin +FCS treated cells on days 1 to
4 were normalized to the total cell protein were subjected to zymography as described in the text. (a) Lane1-4 curcumin + FCS treated cells 1
st
-4
th day, Lane 5-9 control 1
st-4
th day. The activity of MMP-9(b) and MMP-2(c) expressed in arbitrary units of intensity/mm
2/mg protein. Values
given are the average of intensity measurement of 6 experiments ± SEM. (B) ELISA The culture medium collected from controls and curcumin
treated cells in presence of serum at intervals of 24 hrs which were normalized to the total cell protein were quantitated for MMP-9(d) and
MMP-2(e) protein expression by ELISA using specific antibody. Values given are the average of duplicate analysis of 5 experiments ± SEM. *
Statistically significant when compared to their production on first day p < 0.05. # Statistically significant when compared to control p < 0.05.
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nin by lithium on the activity of MMPs was analysed. In
cells treated with Li, no downregulation of MMPs was
observed and there was significant increase in the activ-
ity of both MMP-2 and MMP-9 when compared to the
respective control (Figure 9). In cells treated with curcu-
min along with lithium, the effect of curcumin was
reversed and significant increase in the activities of both
MMP-2 and MMP-9 was observed when compared with
the cells treated with curcumin alone. These results sug-
gest that inhibition of GSK-3 which catalyses serine
phosphorylation of certain proteins including b-catenin
results in reversal of the effect of curcumin on MMP
production. The viability of the cells were not affected
on treatment with lithium, but the extent of grouping
was less and the angiogenic transition was delayed by Li
in both controls and curcumin treated cells.
Discussion
The results presented above indicate the regulation of
the production of matrix metalloproteinases, MMP-2
and MMP-9 by endothelial cells during angiogenesis.
There was significant decrease in the production and
secretion of MMP-2 and MMP-9 with the progression
of culture when grouping of cells and tubular network-
like structure developed. Development of such struc-
tures involves extensive cell-cell contact formation
which correlates with the expression of endothelial cell
markers like CD 31, ICAM-1 and E-selectin that med-
iates cell adhesion and biochemical markers of angio-
genesis such as VEGFR-2, FGFR-1 and VEGF [12,20,21];
thus a reciprocal relation between the expression of
markers of angiogenesis, cell adhesion molecules and
MMPs is evident.
Relation between production of MMP-2 and MMP-9
and angiogenic transition of ECs was also evident from
the results of the experiments on MMP production by
ECs treated with substances such as ursolic acid and cur-
cumin that affect angiogenesis. Angiogenic effect of urso-
lic acid was shown by upregulation of the expression of
angiogenic markers ICAM-1 and angiogenic factors like
V E G Fa n df i b r o b l a s tg r o w t hf a c t o r - 2( F G F - 2 )b yE C s
[20]. Opposing effects of curcumin on angiogenesis is
Figure 5 Production of VE-cadherin in HUVECs (A) RT-PCR: Cells
were maintained in culture in MCDB 131 medium for different time
intervals. Total RNA was isolated and subjected to RT-PCR as
described in the text. Intensity of bands were quantitated and
normalized with the intensity of band for internal control GAPDH
and expressed in intensity units/mm
2 (B). * Statistically significant
when compared to their production on first day p < 0.05.
C. Western blotting HUVECs were maintained in culture in MCDB
131 medium for different time intervals. Medium was removed, the
cells were harvested and lysed in Laemmeli buffer and protein
equivalent amount of the cell lysates were subjected to SDS PAGE
(bottom) and western blot (top) analysis with anti VE-cadherin
antibody as described in the text. Inset, Lane1-4 represents 1
st -4
th
day. The intensity of the immunoblotted bands were measured and
expressed in intensity units/mm
2/mg protein. * Statistically
significant when compared to the production on first day p < 0.05.
Figure 6 Changes in nuclear and cytosolic distribution of
b-catenin in HUVECs: HUVECs were maintained in culture for
different time intervals as described in the text. Medium was
removed, the cells were harvested, fractionated and nuclear and
cytosol were isolated. Protein equivalent amount of the cytosolic
and nuclear fractions were subjected to SDS PAGE and western blot
analysis with anti b-catenin antibody as described in the text.
Lane1-4, 1
st -4
th day (A). The intensity of the immunoblotted bands
were measured and expressed in intensity units/mm
2 (B).
Percentage distribution of b-catenin in the nucleus and cytosol (C) *
Statistically significant when compared to their relative levels in
nucleus and cytosol on first two days p < 0.05.
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Cadherin and b-catenin in HUVECs: Effect of curcumin.
(A) Production of VE Cadherin-Western blotting: HUVECs were
maintained in culture in MCDB 131 medium in presence of
curcumin (10 μM) for different time intervals. Medium was removed,
the cells were harvested and lysed in Laemmeli buffer and protein
equivalent amount of the cell lysates normalized to the total cell
protein were subjected to SDS PAGE (bottom) and western blot
(top) analysis with anti VE-cadherin antibody as described in the
text. Lanes 1-4 represents 1
st -4
th day (A). The intensity of the
immunoblotted bands were measured and expressed in intensity
units/mm
2/mg protein. Values for control in intensity units/mm2
(Day 1: 1256 ± 145, Day 2: 2678 ± 156, Day 3: 2287 ± 189, Day 4:
4018 ± 178) * Statistically significant when compared to the
production on first day p < 0.05. (B) Changes in the distribution
of b-catenin in HUVECs HUVECs were maintained in culture in
presence of curcumin for (10 μM) for different time intervals as
above. The cells were harvested and nuclear and cytosol were
isolated. Protein equivalent amount of the cytosolic and nuclear
fractions were subjected to SDS PAGE and western blot analysis
with anti b-catenin antibody as described in the text. Values for
control in intensity units/mm2/mg protein (Nucleus Day 1: 1877 ±,
145 Day 2: 1687 ± 102, Day 3: 987 ± 89, Day 4: 417 ± 96 and
Cytosol Day 1: 0, Day 2: 0, Day 3: 887 ± 69, Day 4: 1567 ± 58).
Lane1-4 1
st -4
th day (inset). The intensity of the immunoblotted
bands were measured and expressed in intensity units/mm
2/mg
protein (a). Percentage distribution of b-catenin in the nucleus and
cytosol was calculated and expressed in the percentage bar
diagram (b). Values for control (Nucleus Day 1: 100, Day 2: 100, Day
3: 52, Day 4: 21 and Cytosol Day 1: 0, Day 2: 0, Day 3: 48, Day 4: 79).
* Statistically significant when compared to their relative levels in
nucleus and cytosol on first two days p < 0.05.
Figure 8 Phosphorylation of b-catenin. (A) Cell lysates equivalent
to same amount of b-catenin, from cells treated with curcumin
(10 μM) in the absence and presence of serum for different time
intervals were treated with anti-b-catenin antibody. The
immunoprecipitated b-catenin was electrophoresed and
immunoblotted with anti-Phospho-Tyr and Phospho-Ser antibody
(C control, Cu curcumin, FCS (FCS control), CF (Curcumin + FCS).
(B) The intensity of bands were quantitated and the extent of
phosphorylation was expressed as percentage bar diagram. Values
given are average of quarduplicate experiments. * Statistically
significant when compared to the relative ratio in FCS control
p < 0.05.
Figure 9 Effect of lithium chloride on the activity of MMP-2
and MMP-9. HUVECs were maintained in culture with 10 μM
curcumin for 48, 72 and 96 hrs as described in text with and
without GSK-3 inhibitor lithium chloride 1 mM. Medium was
removed and the activities of MMP-2 and MMP-9 were determined
by gelatin zymography. The intensity of MMP-9 and MMP-2 were
measured and expressed in intensity units/mm
2/mg protein. *
Statistically significant when compared to untreated control
p < 0.05.
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genic effect is mediated through VEGF and PI3K-Akt
pathway [21]. Treatment of endothelial cells with these
substances which promoted angiogenic transition of ECs
caused downregulation of MMP-2 and MMP-9. But such
downregulation of MMPs was not produced by aspirin
which inhibited angiogenesis and reduced the production
of cell adhesion molecules [30,31] that promote cell-cell
contact formation.
The downregulation of MMPs minimizes peri-cellular
proteolysis and facilitates the cell-cell/cell-matrix
interactions which are vital for the maturation and
stabilization of neo-vessels. It appears to be endothelial
cell-specific and is related to the angiogenic transition
associated with the formation of cell-cell contact. Other
cell systems such as monoctye/macrophage [32], hepatic
stellate cells [33], hepatocytes [34] and cell lines [35-37]
in culture produced and secreted MMPs which
increased with the progression of the culture. The effect
of curcumin on ECs also appears to be cell type specific
as curcumin did not affect the basal level production of
MMP-2 and MMP-9 by other cell systems such as
monocytes [38]. It caused significant inhibition in the
production and secretion of MMP-2 and MMP-9 by
activated monocytes [38] and cancer cells by inhibiting
the pro-inflammatory transcription factors NFBa n d
AP-1 [39,40]. Further, adhesion proteins such as laminin
and fibronectin, which promoted cell-cell contact and
capillary tube-like structure formation, also caused
downregulation of MMPs that was synchronous with
the formation of cell-cell contact (Unpublished data).
The activity and levels of protein and mRNA of MMP-2
and MMP-9 significantly decreased with the progression
of the culture indicating a downregulation of the expres-
sion of the MMP genes. This does not appear to be a
general effect as several other molecules such as CD31,
E-selectin, ICAM-1 and VE-cadherin increased with the
progression of culture. Although there was no signifi-
cant difference in the activity of MMP-2 and MMP-9
during 24-48 hrs, there was about 10-15% increase in
the level of these proteins determined by ELISA on the
second day (Figure 1 and 2). It is not clear whether this
was due to the difference in the extent of activation of
the proenzyme or due to other factors. The effect of
endogenous inhibitors of MMPs namely tissue inhibitor
of metalloproteinases (TIMPs) which increased under
similar conditions [6] could not be excluded.
During the initial stages when cells remained mostly
as individual ones, there was more MMP-2 and MMP-9
and less VE-cadherin and at later stages when grouping
of cells and network-like structures developed, increase
in VE-cadherin and decrease in MMP-2 and MMP-9
production were observed. Further, curcumin that accel-
erated angiogenic phenotype in HUVECs under serum
free conditions caused a significant upregulation of VE-
cadherin and downregulation of MMPs. Although direct
proof relating cell-cell contact formation and increase in
the levels and distribution of VE-cadherin is not pro-
vided in our present study, there are reports showing
change in cell-cell contact with change in VE-cadherin
expression [41,42]. It has been reported that during the
initial stages of angiogenesis, the levels of VE-cadherin
remained low due to increased endocytosis maintaining
a very low level of this protein on the surface of the ECs
to facilitate their migration and proliferation [43].
Further investigations to understand the signaling
pathways downstream of VE-cadherin suggested the
involvement of b-catenin. There was a relatively high
level of b-catenin in the nucleus of ECs in culture dur-
ing initial stages and decrease in its levels in the nucleus
associated with an increase in the cytosol during later
stages. Apart from contributing to stabilise cell-cell con-
tact through cadherin-catenin association, the transloca-
tion of catenin can result in changes in the expression
of catenin responsive genes. The activity of b-catenin is
regulated by the phosphorylation status of this protein.
Our results on increased tyrosine phosphorylation and
relatively higher levels of b-catenin in the nucleus dur-
ing initial stages (upto 48 hrs) and relative increase in
serine phosphorylation and decreased nuclear distribu-
tion at later stages are consistent with the reported role
of phosphorylation of b-catenin in its translocation from
cytosol to nucleus [44,45]. Further, higher levels of VE-
cadherin observed during later stages of culture may
limit the b-catenin transcriptional activity due to
increase in binding to VE-cadherin [46].
There was correlation between the distribution of
b-catenin in the nucleus and the expression of MMP-2
and MMP-9. As b-catenin in the nucleus decreased with
the progression of the culture, the expression of MMPs
also decreased. Such a down regulation of MMPs was
not observed on treatment with Li which caused
increase in the nuclear distribution of b-catenin. The
down regulation of MMP-2 and MMP-9 caused by cur-
cumin was also reversed by Li. The effect of Li on the
distribution of b-catenin may be related to its phoshory-
lation status as Li is known to inhibit GSK-3 which cat-
alyses phosphorylation of serine in catenin. Similar
results were also obtained on treatment of cells with
SB216763 a specific inhibitor of GSK-3 (data not
shown). However, the possibility of these substances act-
ing on other intracellular pathways cannot be excluded.
Although these results show a correlation between phos-
phorylation status and nuclear distribution of b-catenin
and the levels of MMPs it is not clear whether the
expression of MMP-2 and MMP-9 in HUVECs is
dependent on VE cadherin-b-catenin signaling. MMP
genes are under the influence of the transcriptional
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Although MMP-2 lacks these transcriptional control ele-
ments, it has been reported to be regulated by cadherin
in epithelial cells probablyb yac a t e n i ni n d e p e n d e n t
mechanism [48,49]. Consistent with this, we also
observed downregulation of MMP-2 when the levels of
VE-cadherin increased. The possibility of VE-cadherin
modulating MMP-2 and MMP-9 expression through
b-catenin-independent mechanism cannot be excluded.
Although reciprocal changes in the expression of
MMPs and VE-cadherin were observed in HUVECs in
these different experiments where both pro-angiogenic
and anti-angiogenic substances were tested, it is possible
that these changes may as well be unrelated.
As MMP level decrease probably by other unknown
mechanisms pericellular proteolysis is reduced resulting
in the retention of VE-cadherin and other cell adhesion
molecules promoting cell-cell contact formation. More
direct experiments would be required to confirm this
relationship between the expression of the cell adhesion
molecule in angiogeneiss and modulation of MMP
expression.
Additional material
Additional file 1: Immunocytochemical analysis of the expression
and translocation of b-catenin in HUVECs maintained in culture for
24 hrs. Figure S1 Expression and translocation of b-catenin in
HUVECs: Day1 HUVECs were cultured in MCDB 131 medium and
maintained in culture for 5 days. Cells were harvested at Day 1 (24 hrs)
immunocytochemical analysis was performed to analyze the expression
of b-catenin. Left panel Top to bottom (a) microphotograph of cells Day
1 (40 X) stained with b-catenin, (b) overlaid microphotograph of cells
with nucleus stained (Hoechst stain), (c) phase contrast image of cells
Day 1. Right panel top to bottom, (a) microphotograph of cells Day 1
(100 X) stained with b-catenin, (b) overlaid image with nucleus stained
(Hoechst stain) and (c) microphograph of cells with nucleus stained.
Arrow heads to the b-catenin stained red, nucleus stained blue. The b-
catenin is located in nucleus of the cells during day 1 where the cells are in
single spherical morphology and no cell-cell contact formation observed.
Additional file 2: Immunocytochemical analysis of the expression
and translocation of b-catenin in HUVECs maintained in culture for
120 hrs. Figure S2 Expression and translocation of b-catenin in
HUVECs: Day 5HUVECs were cultured in MCDB 131 medium and
maintained in culture for 5 days (120 hrs). Cells were harvested at Day 5,
and immunocytochemical analysis was performed to analyze the
expression of b-catenin. Left panel Top to bottom microphotograph of
cells Day 5 (40 X) stained with b-catenin, (b) overlaid image of cells with
nucleus stained (Hoechst stain) (c) phase contrast image and (d)
microphotograph of cells with nucleus stained (Hoechst stain). Right
panel Top to bottom, (a) microphotograph of cells Day 5 (100 X) stained
with b-catenin, (b) microphotograph of cells with nucleus stained and (c)
overlaid microphotograph with nucleus stained (Hoechst stain). Arrow
heads to the b-catenin stained red, nucleus stained blue. HUVECs formed
extensive cell-cell contact and capillary network like structure. The b-catenin
is located at the cell contact sites.
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